LEADER 01663oam 2200409 450 001 9910705863403321 005 20170726133331.0 035 $a(CKB)5470000002453782 035 $a(OCoLC)703645500 035 $a(EXLCZ)995470000002453782 100 $a20110225j199805 ua 0 101 0 $aund 135 $aurbn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 13$aAn assessment of molten metal detachment hazards for electron beam welding in the space environment: analysis and test results /$fA.C. Nunes [and three others] 210 1$aHuntsville, Alabama :$cNational Aeronautics and Space Administration, Marshall Space Flight Center,$dMay 1998. 215 $a1 online resource (v, 19 pages) $cillustrations 225 1 $aNASA/TM ;$v1998-207979 300 $a"May 1998." 300 $a"Performing organization: George C. Marshall Space Flight Center"--Report documentation page. 320 $aIncludes bibliographical references (page 19). 517 $aAssessment of molten metal detachment hazards for electron beam welding in the space environment 606 $aElectron beam welding$2nasat 606 $aAerospace environments$2nasat 615 7$aElectron beam welding. 615 7$aAerospace environments. 700 $aNunes$b A. C.$01399557 712 02$aGeorge C. Marshall Space Flight Center, 801 0$bSSM 801 1$bSSM 801 2$bGPO 906 $aBOOK 912 $a9910705863403321 996 $aAn assessment of molten metal detachment hazards for electron beam welding in the space environment: analysis and test results$93549113 997 $aUNINA LEADER 04222oam 22009974a 450 001 9910791952803321 005 20220930231400.0 010 $a1-78170-231-4 010 $a1-84779-301-0 024 7 $a10.7765/9781847793010 035 $a(CKB)2560000000085712 035 $a(EBL)1069642 035 $a(OCoLC)818847401 035 $a(SSID)ssj0000712724 035 $a(PQKBManifestationID)12259410 035 $a(PQKBTitleCode)TC0000712724 035 $a(PQKBWorkID)10646006 035 $a(PQKB)10652537 035 $a(StDuBDS)EDZ0000086812 035 $a(MiAaPQ)EBC1069642 035 $a(Au-PeEL)EBL1069642 035 $a(CaPaEBR)ebr10623281 035 $a(CaONFJC)MIL843589 035 $a(MdBmJHUP)musev2_78485 035 $a(DE-B1597)659951 035 $a(DE-B1597)9781847793010 035 $a(PPN)254976239 035 $a(EXLCZ)992560000000085712 100 $a20110105d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe BBC and national identity in Britain, 1922?53$fThomas Hajkowski 210 1$aNew York (N.Y.) :$cManchester University Press,$d2010. 210 4$dİ2010. 215 $a1 online resource (265 p.) 225 0 $aStudies in popular culture 300 $aDescription based upon print version of record. 311 $a0-7190-7944-6 320 $aIncludes bibliographical references (p. [239]-246) and index. 327 $a"Jolly proud you are a Britisher:" empire and identity, 1923-39 -- From the war to Westminster Abbey: the BBC and the empire, 1939-53 -- The BBC and the making of a multi-national monarchy -- Rethinking regional broadcasting in Britain, 1922-53 -- Broadcasting a nation: the BBC and national identity in Scotland -- BBC broadcasting in Wales, 1922-53 -- This is Northern Ireland: regional broadcasting and identity in "Ulster". 330 $aExamining the ways in which the BBC constructed and disseminated British national identity during the second quarter of the twentieth century, this book is the first study that focuses in a comprehensive way on how the BBC, through its radio programs, tried to represent what it meant to be British. The BBC and national identity in Britain offers a revision of histories of regional broadcasting in Britain that interpret it as a form of cultural imperialism. The regional organization of the BBC, and the news and creative programming designed specifically for regional listeners, reinforced the cu 410 0$aStudies in popular culture (Manchester, England) 606 $a1922-1953$2rero 606 $aidentite? nationale$2rerovoc 606 $acommunication de masse$2rerovoc 606 $aNationalisme$xDans les medias$zGrande-Bretagne$2ram 606 $aRadio broadcasting$2fast$3(OCoLC)fst01087224 606 $aNationalism$2fast$3(OCoLC)fst01033832 606 $aMass media and nationalism$2fast$3(OCoLC)fst01742693 606 $aNationalism$zGreat Britain$xHistory$y20th century 606 $aRadio broadcasting$zGreat Britain$xHistory 606 $aMass media and nationalism$zGreat Britain 607 $aGrande-Bretagne$2rero 607 $aGreat Britain$2fast 608 $aHistory. 610 $aBBC. 610 $aBritish imperialism. 610 $aBritish national identity. 610 $acultural imperialism. 610 $adual identities. 610 $amass media. 610 $amedia history. 610 $anationalism. 610 $aradio programmes. 610 $aregional broadcasting. 615 7$a1922-1953. 615 7$aidentite? nationale. 615 7$acommunication de masse. 615 7$aNationalisme$xDans les medias 615 7$aRadio broadcasting. 615 7$aNationalism. 615 7$aMass media and nationalism. 615 0$aNationalism$xHistory 615 0$aRadio broadcasting$xHistory. 615 0$aMass media and nationalism 676 $a302.23440941 700 $aHajkowski$b Thomas$01478848 801 0$bMdBmJHUP 801 1$bMdBmJHUP 906 $aBOOK 912 $a9910791952803321 996 $aThe BBC and national identity in Britain, 1922?53$93694681 997 $aUNINA LEADER 05649nam 2200649Ia 450 001 9910163021603321 005 20200520144314.0 010 $a1-283-15352-1 010 $a9786613153524 010 $a3-8055-9195-0 035 $a(CKB)2610000000006643 035 $a(EBL)3016399 035 $a(SSID)ssj0000543418 035 $a(PQKBManifestationID)12207063 035 $a(PQKBTitleCode)TC0000543418 035 $a(PQKBWorkID)10519109 035 $a(PQKB)11661469 035 $a(MiAaPQ)EBC3016399 035 $a(OCoLC)655261985 035 $a(SZ-BaSKA)249897 035 $a(PPN)146226895 035 $a(EXLCZ)992610000000006643 100 $a20100127d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCurrent indications for growth hormone therapy /$fvolume editor, Peter C. Hindmarsh 205 $a2nd, rev. ed. 210 $aBasel ;$aNew York $cKarger$d2010 215 $a1 online resource (136 p.) 225 0 $aEndocrine development,$x1421-7082 ;$vv. 18 300 $aDescription based upon print version of record. 311 $a3-8055-9194-2 320 $aIncludes bibliographical references and indexes. 327 $a""Cover""; ""Contents""; ""Preface""; ""Chapter 1: Clinical Trials: Planning and Analysis""; ""Abstract""; ""Introduction""; ""Statistical Structure for Planning of Trials""; ""Randomization""; ""Outcomes in Studies of Growth Hormone Therapy""; ""Longitudinal Measurements""; ""Multiple Outcomes""; ""Issues Related to Trial Design""; ""Interpretation of Negative Trials""; ""Non-Inferiority Trials""; ""Conclusion""; ""References""; ""Chapter 2: The Evidence Base for Growth Hormone Effectiveness in Children""; ""Abstract""; ""Evidence Is Not Truth a??? How Do We Know What We Know?"" 327 $a""GH Therapy a??? How Do We Define Benefit and What Is the Evidence?""""Height Screening/Monitoring""; ""Bone Age and Predicted Height as a Surrogate""; ""Where Does Evidence-Based Child Health Fit in Endocrinology""; ""Conclusions""; ""References""; ""Chaper 3: Safety of Recombinant Human GrowthHormone""; ""Abstract""; ""Short-Term Safety Issues""; ""Longer Term Safety Considerations""; ""Tumour Risk and Growth Hormone Treatment""; ""Conclusion""; ""References""; ""Chapter 4: Diagnosis of Growth Hormone Deficiency""; ""Abstract""; ""Introduction""; ""Clinical Examination and Auxology"" 327 $a""Measuring GH Secretion""""Using Downstream Targets of GH Action a??? IGF-1 and IGFBP-3""; ""Neuroradiology""; ""Conclusions""; ""References""; ""Chapter 5: Biological Determinants of Responsiveness to Growth Hormone: Pharmacogenomics and Personalized Medicine""; ""Abstract""; ""Introduction""; ""Pharmacogenomics of Growth""; ""GH Insensitivity (GHI)""; ""GH Receptor""; ""Altered GHR Signaling""; ""Growth Responsiveness to GH Therapy, the Impact of the Growth Plate""; ""Conclusions""; ""References"" 327 $a""Chapter 6: Clinical Considerations in Using Growth Hormone Therapy in Growth Hormone Deficiency""""Abstract""; ""Introduction""; ""Growth Hormone Therapy""; ""Conclusions""; ""References""; ""Chapter 7: Current Indications for Growth Hormone Therapy for Children and Adolescents""; ""Abstract""; ""Introduction""; ""Growth Hormone Deficiency (GHD)""; ""Chronic Renal Insufficiency (CRI), also Known as Chronic Kidney Disease (CKD)""; ""Turner Syndrome (TS)""; ""Children Born Small-for-Gestational Age (SGA), Who Fail to Catch Up to the Normal Growth Channels""; ""Prader-Willi Syndrome (PWS)"" 327 $a""Idiopathic Short Stature (ISS)""""SHOX Gene Haploinsufficiency (SHOX)""; ""Noonan Syndrome (NS)""; ""Conclusions""; ""References""; ""Chapter 8: GH Use in the Transition of Adolescence to Adulthood""; ""Abstract""; ""Introduction""; ""Who, When and How Do We Retest for GH Deficiency during Transition?""; ""Efficacy Data""; ""Dose""; ""Follow-Up""; ""Conclusions""; ""References""; ""Author Index""; ""Subject Index"" 330 $aGrowth hormone (GH) has been used therapeutically for over 50 years. Since the development of a nearly unlimited supply of recombinant human GH in the mid-1980s, children with less severe GH deficiency can also profit from GH replacement therapy. Careful and accurate diagnosis and specific dosing, both essential to ensure normal height development, require the clinician to understand the finer points of clinical trials, to acquire quality evidence and assess the benefits of therapeutic intervention. Furthermore, genetic and environmental factors influencing GH sensitivity and responsiveness need to be taken into account. In this second edition all these aspects are covered in depth. Clinical examination, detailed auxological measurements, bone age assessment, molecular analysis and neuro-radiological evaluation as well as an adaptive strategy of dosing focusing on a patient?s individual responsiveness are discussed in detail. This volume of Endocrine Development is essential reading for pediatric endocrinologists, pediatricians and clinical nurse specialists involved in GH therapy. 410 0$aEndocrine Development 606 $aSomatotropin$xTherapeutic use 606 $aSomatotropin$vPopular works 615 0$aSomatotropin$xTherapeutic use. 615 0$aSomatotropin 676 $a615/.363 686 $a610$2sdnb 701 $aHindmarsh$b P. C$g(Peter C.)$0960349 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910163021603321 996 $aCurrent indications for growth hormone therapy$92788817 997 $aUNINA